Search Within

Ross Levine

  1. "MSK Grad Students"
Formats
  1. Journal Article (37)
  2. Meeting Abstract (16)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Adult Leukemia (55)
  2. Center for Hematologic Malignancies (55)
  3. Department of Medicine (55)
  4. Executive Committee, Center for Hematologic Malignancies (55)
  5. GSK Faculty (55)
  6. Hematologic Malignancies, Division of (55)

More Groups

People
  1. Franck Rapaport (11)
  2. Martin Tallman (11)
  3. Brittany Woods (10)
  4. Richard Koche (10)
  5. Andrew Dunbar (9)
  6. Young Park (9)

More People

Years
  1. 2024 (5)
  2. 2023 (4)
  3. 2022 (3)
  4. 2021 (6)
  5. 2020 (4)
  6. 2019 (3)

More Years

Publications
  1. Blood (20)
  2. Cancer Cell (5)
  3. Cancer Discovery (3)
  4. Nature (3)
  5. Nature Genetics (3)
  6. Clinical Cancer Research (2)

More Publications

Publishers
  1. American Society of Hematology (20)
  2. Nature Publishing Group (8)
  3. American Association for Cancer Research (6)
  4. Cell Press (6)
  5. American Society for Clinical Investigation (2)
  6. American Association for the Advancement of Science (1)

More Publishers

Results (55)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Automated real-world data integration improves cancer outcome prediction
    Journal Article

    Jee, J.; Fong, C.; Pichotta, K.; Tran, T. N.; Luthra, A.; Waters, M.; Fu, C.; Altoe, M.; Liu, S. Y.; Maron, S. B.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy
    Journal Article

    Bowman, R. L.; Dunbar, A. J.; Mishra, T.; Xiao, W.; Waarts, M. R.; Maestre, I. F.; Eisman, S. E.; Cai, L.; Mowla, S.; Shah, N.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • CRISPR dependency screens in primary hematopoietic stem cells identify KDM3B as a genotype-specific vulnerability in IDH2- and TET2-mutant cells
    Journal Article

    Waarts, M. R.; Mowla, S.; Boileau, M.; Martinez Benitez, A. R.; Sango, J.; Bagish, M.; Fernández-Maestre, I.; Shan, Y.; Eisman, S. E.; Park, Y. C.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Jak2(V617F) reversible activation shows its essential requirement in myeloproliferative neoplasms
    Journal Article

    Dunbar, A. J.; Bowman, R. L.; Park, Y. C.; O'Connor, K.; Izzo, F.; Myers, R. M.; Karzai, A.; Zaroogian, Z.; Kim, W. J.; Fernandez-Maestre, I.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Developing a membrane-proximal CD33-targeting CAR T cell
    Journal Article

    Freeman, R.; Shahid, S.; Khan, A. G.; Mathew, S. C.; Souness, S.; Burns, E. R.; Um, J. S.; Tanaka, K.; Cai, W.; Yoo, S.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Associations between cancer predisposition mutations and clonal hematopoiesis in patients with solid tumors
    Journal Article

    Franch-Expósito, S.; Mehine, M.; Ptashkin, R. N.; Bolton, K. L.; Bandlamudi, C.; Srinivasan, P.; Zhang, L.; Goodell, M. A.; Gedvilaite, E.; Menghrajani, K.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia
    Meeting Abstract

    Sirenko, M.; Lee, S.; Sun, Z.; Chaligne, R.; Asimomitis, G.; Brierley, C. K.; Bernard, E.; Cai, S. F.; Myers, R. M.; Nadorp, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Hematopoietic-specific heterozygous loss of DNMT3A exacerbates colitis-associated colon cancer
    Journal Article

    Feng, Y.; Yuan, Q.; Newsome, R. C.; Robinson, T.; Bowman, R. L.; Zuniga, A. N.; Hall, K. N.; Bernsten, C. M.; Shabashvili, D. E.; Krajcik, K. I.; more...
    Journal of Experimental Medicine (2023)

    Fulltext@MSK | Save
  • CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis
    Journal Article

    Dunbar, A. J.; Kim, D.; Lu, M.; Farina, M.; Bowman, R. L.; Yang, J. L.; Park, Y.; Karzai, A.; Xiao, W.; Zaroogian, Z.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • JAK2(V617F) reversible activation shows an essential requirement for JAK2(V617F) in myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Dunbar, A.; Bowman, R. L.; Park, Y.; Izzo, F.; Myers, R. M.; Karzai, A.; Kim, W. J.; Maestre, I. F.; Waarts, M. R.; Nazir, A.; more...
    Blood (2022)

    Fulltext@MSK | Save